Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial.
Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, Fansler A, Van de Bruinhorst K, Janis S, Durkalski-Mauldin VL; Neurological Emergencies Treatment Trials Network and the SHINE Trial Investigators. Johnston KC, et al. Among authors: durkalski mauldin vl. JAMA. 2019 Jul 23;322(4):326-335. doi: 10.1001/jama.2019.9346. JAMA. 2019. PMID: 31334795 Free PMC article. Clinical Trial.
The EPISOD study: long-term outcomes.
Cotton PB, Pauls Q, Keith J, Thornhill A, Drossman D, Williams A, Durkalski-Mauldin V. Cotton PB, et al. Gastrointest Endosc. 2018 Jan;87(1):205-210. doi: 10.1016/j.gie.2017.04.015. Epub 2017 Apr 25. Gastrointest Endosc. 2018. PMID: 28455162
Treatment of Hyperglycemia in Patients With Acute Stroke-Reply.
Bruno A, Johnston KC, Durkalski-Mauldin VL; SHINE Trial Investigators. Bruno A, et al. Among authors: durkalski mauldin vl. JAMA. 2019 Dec 10;322(22):2248-2249. doi: 10.1001/jama.2019.16342. JAMA. 2019. PMID: 31821427 No abstract available.
Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, Van Huysen C, Stevenson VLW, Yadav K, Jones CW, Kea B, Burnett A, Reynolds JC, Greineder CF, Haas NL, Beiser DG, Silbergleit R, Barsan W, Callaway CW; SIREN-C3PO Investigators. Korley FK, et al. N Engl J Med. 2021 Nov 18;385(21):1951-1960. doi: 10.1056/NEJMoa2103784. Epub 2021 Aug 18. N Engl J Med. 2021. PMID: 34407339 Free PMC article. Clinical Trial.
COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response.
McDyer JF, Azimpouran M, Durkalski-Mauldin VL, Clevenger RG, Yeatts SD, Deng X, Barsan W, Silbergleit R, El Kassar N, Popescu I, Dimitrov D, Li W, Lyons EJ, Lieber SC, Stone M, Korley FK, Callaway CW, Dumont LJ, Norris PJ; The SIREN-C3PO Investigators. McDyer JF, et al. Among authors: durkalski mauldin vl. JCI Insight. 2023 Apr 24;8(8):e167890. doi: 10.1172/jci.insight.167890. JCI Insight. 2023. PMID: 36862515 Free PMC article.
Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population.
Welch RD, Nicholas K, Durkalski-Mauldin VL, Lowenstein DH, Conwit R, Mahajan PV, Lewandowski C, Silbergleit R; Neurological Emergencies Treatment Trials (NETT) Network Investigators. Welch RD, et al. Epilepsia. 2015 Feb;56(2):254-62. doi: 10.1111/epi.12905. Epub 2015 Jan 17. Epilepsia. 2015. PMID: 25597369 Free PMC article. Clinical Trial.
26 results